Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

DPAG Professor one of three researchers from Oxford University who received prestigious awards from the Royal Society in recognition of their work in the fields of science and medicine.

The Croonian Medal and Lecture has been awarded to Professor Dame Kay Davies FMedSci FRS of Oxford’s Department of Physiology, Anatomy and Genetics (DPAG) for her achievements in developing a prenatal test for Duchenne muscular dystrophy and for her work characterising the binding partners of the protein dystr-ophin. 

Duchenne muscular dystrophy is a progressive muscle wasting disease which affects mostly boys, who often need wheelchairs at about 12 years of age and die in their twenties, usually from respiratory or cardiac problems. There is currently no effective treatment. Kay’s work has resulted in treatments poised to transform the lives of an estimate 250,000 patients worldwide.

Professor Tamsin Mather, Professor of Earth Science at the University of Oxford, was awarded the Rosalind Franklin Award for her work in the field of volcanology, and Professor Ian Walmsley FRS of Oxford’s Department of Physics was awarded the Rumford Medal for his pioneering work in the quantum control of light and matter on ultrashort timescales.

Find out more (University of Oxford website)

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.